ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VIRI Virios Therapeutics Inc

0.443
-0.0128 (-2.81%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 40,647
Bid Price 0.442
Ask Price 0.48
News -
Day High 0.4749

Low
0.279

52 Week Range

High
2.42

Day Low 0.44
Share Name Share Symbol Market Stock Type
Virios Therapeutics Inc VIRI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0128 -2.81% 0.443 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.4609 0.44 0.4749 0.4695 0.4558
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
130 40,647 US$ 0.4554253 US$ 18,512 - 0.279 - 2.42
Last Trade Type Quantity Price Currency
18:54:44 formt 450 US$ 0.443 USD

Virios Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.05M 19.26M - 0 -5.3M -0.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Virios Therapeutics News

Date Time Source News Article
3/26/202408:15GlobeNewswire Inc.Virios Therapeutics Announces Publication of International..
3/08/202416:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
3/06/202415:30Edgar (US Regulatory)Form 8-K - Current report
3/01/202408:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202408:25Edgar (US Regulatory)Form 8-K - Current report
2/29/202408:15GlobeNewswire Inc.Virios Therapeutics Announces Fourth Quarter and Full Year..
2/28/202412:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202411:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202411:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202411:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202411:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VIRI Message Board. Create One! See More Posts on VIRI Message Board See More Message Board Posts

Historical VIRI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4590.47490.4010.431686494,282-0.016-3.49%
1 Month0.48630.580.4010.4952413186,518-0.0433-8.90%
3 Months0.420.62880.2790.4327987313,1720.0235.48%
6 Months0.51411.040.2790.5949792396,011-0.0711-13.83%
1 Year0.932.420.2791.05537,508-0.487-52.37%
3 Years5.619.11090.2189511.09494,756-5.17-92.10%
5 Years13.7614.390.2189511.57474,679-13.32-96.78%

Virios Therapeutics Description

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia.

Your Recent History

Delayed Upgrade Clock